ARCA biopharma to Distribute Special Dividend Conditional on Shareholder Approval of Oruka Therapeutics Merger
ARCA biopharma (ABIO) said late Friday that it will distribute a special dividend estimated to be $1.59 per share, subject to approval of the proposed merger with Oruka Therapeutics by ARCA shareholders.
The exact amount of the dividend will be based on the merger agreement and ARCA's estimate of how much its net cash exceeds $5 million before the merger closes, the company said.
The dividend is payable on Aug. 28 to shareholders of record on Aug. 26, the company said.
The proposed merger is expected to close on Aug. 29.
Shares of ARCA were up about 13% in recent after-hours activity.
Price: 3.3200, Change: +0.37, Percent Change: +12.54
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.